Evidence map›Paper›PMID 35351246›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Randomized trial findings suggest an uncertain trail ahead for TB digital adherence technologies.

R Subbaraman, K Fielding, W Thies, K Schwartzman

Abstract readComment
PubMed Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

R SubbaramanDepartment of Public Health and Community Medicine and Center for Global Public Health, Tufts University School of Medicine, Boston, MA, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA.
K FieldingTB Centre, London School of Hygiene & Tropical Medicine, London, UK.
W ThiesMicrosoft Research India, Bangalore, Karnataka, India, Everwell Health Solutions, Bangalore, Karnataka, India.
K SchwartzmanMontreal Chest Institute, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, McGill International Tuberculosis Centre, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDirectly Observed TherapyTuberculosisHumansRandomized Controlled Trials as TopicAntitubercular Agents

Identifiers

PMID35351246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.